Compare SXTC & HLP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SXTC | HLP |
|---|---|---|
| Founded | 2005 | 2021 |
| Country | China | China |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Industrial Machinery/Components |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 92.9M | 76.4M |
| IPO Year | 2017 | 2021 |
| Metric | SXTC | HLP |
|---|---|---|
| Price | $1.99 | $1.11 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 42.2K | ★ 3.3M |
| Earning Date | 08-19-2019 | 05-08-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $51.63 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.03 | $0.34 |
| 52 Week High | $6.98 | $1.72 |
| Indicator | SXTC | HLP |
|---|---|---|
| Relative Strength Index (RSI) | 40.74 | 69.04 |
| Support Level | $1.95 | $0.88 |
| Resistance Level | $2.21 | $1.21 |
| Average True Range (ATR) | 0.32 | 0.15 |
| MACD | -0.05 | 0.02 |
| Stochastic Oscillator | 27.36 | 78.20 |
China SXT Pharmaceuticals Inc is a pharmaceutical company that is focused on the research, development, manufacture, marketing, and sales of Traditional Chinese Medicine Pieces (TCMP), particularly TCMP (Directed-oral TCMP and After-soaking TCMP), which is a sort of Traditional Chinese Medicine (TCM) that has been processed to be ready for use without decoction. Geographically, the firm generates its revenue from the People's Republic of China.
Hongli Group Inc is a cold roll-formed steel profile manufacturer in China. It customizes and manufactures cold roll-formed steel profiles for machinery and equipment in a variety of sectors, including but not limited to mining and excavation, construction, agriculture, and transportation. Geographically, the company generates the majority of its revenue from the PRC.